IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 7, 2016, Pages 977-988

  Anderson, E L ^a   Kobayashi, T ^b   Iijima, K ^b   Bartemes, K R ^a   Chen, C C ^a   Kita, Hirohito ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

eosinophilopoiesis; eosinophils; IL 33; IL 5

Indexed keywords

ALLERGEN; ANTIBODY; CYTOKINE; INTERLEUKIN 33; INTERLEUKIN 5;

ALTERNARIA ALTERNATA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATMOSPHERE; BLOOD LEVEL; BONE MARROW; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EOSINOPHIL; EOSINOPHILOPOIESIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; LUNG; LYMPHOID CELL; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BLOOD; EOSINOPHILIA; GENETICS; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; MYELOPOIESIS; PATHOLOGY;

ALLERGENS; ANIMALS; BONE MARROW; ENVIRONMENTAL EXPOSURE; EOSINOPHILIA; EOSINOPHILS; FEMALE; INTERLEUKIN-33; INTERLEUKIN-5; LEUKOCYTE COUNT; LUNG; MICE; MYELOPOIESIS;

EID: 84959571948     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12861     Document Type: Article

References (44)

1. Wenzel SE,. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
2. Rothenberg ME, Hogan SP,. The eosinophil. Annu Rev Immunol 2006; 24: 147-174.
3. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, et al., Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148: 713-719.
4. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ,. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197: 1167-1172.
5. Bochner BS, Schleimer RP,. Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev 2001; 179: 5-15.
6. Manz MG, Boettcher S,. Emergency granulopoiesis. Nat Rev Immunol 2014; 14: 302-314.
7. Askenase MH, Han SJ, Byrd AL, Morais da Fonseca D, Bouladoux N, Wilhelm C, et al., Bone-Marrow-Resident NK cells prime monocytes for regulatory function during infection. Immunity 2015; 42: 1130-1142.
8. Lambrecht BN, Hammad H,. The airway epithelium in asthma. Nat Med 2012; 18: 684-692.
9. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC,. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007; 120: 1279-1284.
10. Cayrol C, Girard JP,. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 2014; 31: 31-37.
11. Sims JE, Smith DE,. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10: 89-102.
12. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H,. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011; 186: 4375-4387.
13. Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H,. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 2009; 123: 1047-1054.
14. Doherty TA, Khorram N, Sugimoto K, Sheppard D, Rosenthal P, Cho JY, et al., Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness. J Immunol 2012; 188: 2622-2629.
15. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H,. IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 2012; 188: 1503-1513.
16. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, et al., Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013; 502: 245-248.
17. Roediger B, Kyle R, Le Gros G, Weninger W,. Dermal group 2 innate lymphoid cells in atopic dermatitis and allergy. Curr Opin Immunol 2014; 31: 108-114.
18. Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015; 519: 242-246.
19. Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A, et al., Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013; 210: 535-549.
20. Lee MW, Odegaard JI, Mukundan L, Qiu L, Molofsky AB, Nussbaum JC, et al., Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015; 160: 74-87.
21. Snelgrove RJ, Gregory LG, Peiro T, Akthar S, Campbell GA, Walker SA, et al., Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol 2014; 134: 583-592.
22. Boitano S, Flynn AN, Sherwood CL, Schulz SM, Hoffman J, Gruzinova I, et al., Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2. Am J Physiol Lung Cell Mol Physiol 2011; 300: L605-L614.
23. Bush RK, Prochnau JJ,. Alternaria-induced asthma. J Allergy Clin Immunol 2004; 113: 227-234.
24. Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM,. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999; 21: 473-479.
25. Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB,. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997; 17: 404-413.
26. Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O'Byrne PM,. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998; 157: 99-105.
27. Rose S, Misharin A, Perlman H,. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry A 2012; 81: 343-350.
28. Takatsu K, Nakajima H,. IL-5 and eosinophilia. Curr Opin Immunol 2008; 20: 288-294.
29. Busse WW, Ring J, Huss-Marp J, Kahn JE,. A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma. J Allergy Clin Immunol 2010; 125: 803-813.
30. Wood LJ, Sehmi LJ, Dorman S, Hamid Q, Tulic MK, Watson RM, et al., Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med 2002; 166: 883-889.
31. Minshall EM, Schleimer R, Cameron L, Minnicozzi M, Egan RW, Gutierrez-Ramos JC, et al., Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med 1998; 158: 951-957.
32. Bartemes KR, Kita H,. Dynamic role of epithelium-derived cytokines in asthma. Clin Immunol 2012; 143: 222-235.
33. Divekar R, Kita H,. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol 2015; 15: 98-103.
34. Hardman CS, Panova V, McKenzie AN,. IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013; 43: 488-498.
35. Walker JA, Barlow JL, McKenzie AN,. Innate lymphoid cells-how did we miss them? Nat Rev Immunol 2013; 13: 75-87.
36. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM,. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-626.
37. Matsuwaki Y, Wada K, Moriyama H, Kita H,. Human eosinophil innate response to Alternaria fungus through protease-activated receptor-2. Int Arch Allergy Immunol 2011; 155 (Suppl. 1): 123-128.
38. Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, et al., The alarmin IL-33 is a notch target in quiescent endothelial cells. Am J Pathol 2012; 181: 1099-1111.
39. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht BN, et al., Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med 2012; 209: 1505-1517.
40. Christianson CA, Goplen NP, Zafar I, Irvin C, Goot JT Jr, Rollins DR, et al., Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 2015; 136: 59-68.
41. Menzies-Gow A, Flood-Page P, Sehmi R, Murman J, Hamid Q, Robinson DS, et al., Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003; 111: 714-719.
42. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF,. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 2008; 181: 4004-4009.
43. Fulkerson PC, Schollaert KL, Bouffi C, Rothenberg ME,. IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation. J Immunol 2014; 193: 4043-4052.
44. Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC,. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999; 29: 1496-1503.